Key investments in technology, temperature-control capabilities and customer service aim to make company a global leader in biological specimen transportation
UPS (NYSE: UPS) today announced a significant global expansion of its healthcare-specific capabilities to support clinical trials. UPS’s investments in a range of specialized solutions will help pharmaceutical companies and clinical investigators move sensitive materials and specimens globally, particularly in and out of complex geographies.